MIR3118-1

Across TCGA pan-cancer cohorts, MIR3118-1 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated MIR3118-1 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher MIR3118-1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3118-1 expression acts as an unfavorable survival marker.

KIRC, STAD, and KIRP are the cancer types where MIR3118-1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.133	0.631	<.001	90	view →
STAD	OS	Tertile	All	0.061	0.731	<.001	36	view →
KIRP	DFS	Tertile	All	0.277	0.867	.004	18	view →
PRAD	OS	Tertile	All	0.826	0.990	<.001	18	view →
SARC	OS	Tertile	All	0.174	0.745	.005	18	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

MIR3118-1–KIRC (OS)

Open the KIRC breakdown →